XML 55 R37.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Financial Information (Parent Company Only) (Tables)
 12 Months Ended
Dec. 31, 2025
Condensed Financial Information Disclosure [Abstract]  
Schedule of Condensed Balance Sheets Information
 December 31,
2025		December 31,
2024
Assets
Investment in subsidiary$520,283 $425,033 
Total assets$520,283 $425,033 
Liabilities and Stockholders' Equity
Due to subsidiary16,061 1,762 
Accrued expenses1,769 1,992 
Long-term debt, net of debt issuance costs323,176 321,428 
Total liabilities$341,006 $325,182 
Commitments and Contingencies (Note 14)
Stockholders' Equity:
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2025 and 2024, respectively; no shares issued and outstanding as of December 31, 2025 and 2024
— — 
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 204,153,619 and 191,778,639 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively
205 192 
Additional paid-in-capital1,188,089 1,107,952 
Accumulated deficit(1,009,017)(1,008,293)
Total Alignment Healthcare, Inc. stockholders' equity179,277 99,851 
Total liabilities and stockholders' equity$520,283 $425,033 
Schedule Condensed Statements of Operations Information
 Year Ended December 31,
 202520242023
Revenues:
Total revenues$— $— $— 
Expenses:
Selling, general, and administrative expenses530 443 488 
Total expenses530 443 488 
Loss from operations(530)(443)(488)
Other expenses:
Interest expense15,786 1,700 — 
Total other expenses15,786 1,700 — 
Loss before income taxes(16,316)(2,143)(488)
Provision for income taxes16 — — 
Net loss of Parent Company(16,332)(2,143)(488)
Subsidiary's Net income (loss)15,354 (125,928)(147,685)
Net loss(978)(128,071)(148,173)
Less: Net loss attributable to noncontrolling interest(254)(36)(156)
Net loss attributable to Alignment Healthcare, Inc.$(724)$(128,035)$(148,017)
Schedule of Condensed Statements of Cash Flows Information
 Year Ended December 31,
 202520242023
Operating Activities:
Net loss attributable to Alignment Healthcare, Inc.$(724)$(128,035)$(148,017)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity in loss of subsidiary(15,100)125,892 147,529 
Amortization of debt issuance costs1,761 220 — 
Due to subsidiary14,063 1,923 488 
Net cash provided by operating activities— — — 
Investing Activities:
Investment in Subsidiary(18,068)(321,525)— 
Net cash used in investing activities(18,068)(321,525)— 
Financing Activities:
Shares withheld net of restricted stock— (350)— 
Stock options exercised18,068 155 — 
Proceeds from long-term debt— 330,000 — 
Debt issuance costs— (8,280)— 
Net cash provided by financing activities18,068 321,525 — 
Net (decrease) increase in cash— — — 
Cash, cash equivalents and restricted cash at beginning of period— — — 
Cash, cash equivalents and restricted cash at end of period$— $— $— 
Supplemental non-cash financing and investing activities:
Contribution of equity to subsidiary related to equity-based compensation$62,082 $71,132 $66,835 
Debt issuance costs in accounts payable$26 $512 $—